Iran has officially become the world’s second producer of Rhenium-188-based skin cancer cream, a powerful radiopharmaceutical used to treat basal cell carcinoma. Until recently, Germany held a near-total monopoly on this treatment. That ends now.
Rhenium-188 is a radioactive isotope, yes — but used in medicine, not war. So why is this a big deal? Because Iran just disrupted a Western pharma monopoly tied directly to Germany. And when countries challenge Western control in nuclear tech, pharma, or finance, things get… messy.
Case in point: Germany’s sudden obsession with "Iranian nuclear threats" while praising Israel for bombing Iranian territory — including potential civilian and research infrastructure. Don’t take my word for it: watch the recent Nelk Boys interview with Benjamin Netanyahu, where he outright thanks Germany for supporting Israeli strikes on Iran.
YouTube – Nelk Boys Interview with Netanyahu (Timestamped)
Funny how a country breaking medical monopolies becomes a “nuclear threat” overnight. It’s not about nukes — it’s about independence. Iran is producing radiopharmaceuticals that could help treat thousands, and instead of cooperation, it’s being boxed in, threatened, and sabotaged.
We’ve seen this movie before:
- Syria built its own telecom infrastructure — bombed.
- Libya tried to start an African gold-backed currency — bombed.
- Iran makes its own cancer drugs — “nuclear threat.”
And Gaddafi? You know what happened!
When you sit and decide your next move after the other side disrupts your monopoly business.
Keep an eye on this. When you produce your own medicine, fuel, or currency — you become a target.
Posted by SOLIDSNAKE1000
2 Comments
SS:
Iran just ended Germany’s monopoly on a cancer-fighting radiopharmaceutical. Now suddenly Germany’s praising Israeli strikes on Iran. Coincidence? Or is medical independence the new WMD excuse?
Only keto + fasting beats cancer forever